• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-206 通过靶向 CDK9 抑制肝癌细胞的生长。

miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9.

机构信息

Department of Biochemistry and Molecular Biology, Hainan Medical College, Haikou, 570102, China.

Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Third Military Medical University, Chongqing, 400038, China.

出版信息

Cancer Med. 2017 Oct;6(10):2398-2409. doi: 10.1002/cam4.1188. Epub 2017 Sep 21.

DOI:10.1002/cam4.1188
PMID:28940993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5633544/
Abstract

miR-206 plays an important role in regulating the growth of multiple cancer cells. Cyclin-dependent kinase 9 (CDK9) stimulates the production of abundant prosurvival proteins, leading to impaired apoptosis of cancer cells. However, it is unknown whether CDK9 is involved in the miR-206-mediated growth suppression of hepatocellular carcinoma (HCC) cells. In this study, we found that the expression level of miR-206 was significantly lower in HCC cell lines than that in normal hepatic cell line (L02). Meanwhile, CDK9 was upregulated in HCC cell lines. Moreover, miR-206 downregulated CDK9 in HCC cells via directly binding to its mRNA 3' UTR, which resulted in a decrease of RNA PolII Ser2 phosphorylation and Mcl-1 level. Additionally, miR-206 suppressed the cell proliferation, and induced cell cycle arrest and apoptosis. Similarly, silence or inhibition of CDK9 also repressed the cell proliferation, and induced cell cycle arrest and apoptosis. Taken together, the results demonstrated that miR-206 inhibited the growth of HCC cells through targeting CDK9, suggesting that the miR-206-CDK9 pathway may be a novel target for the treatment of HCC.

摘要

miR-206 在调节多种癌细胞的生长中发挥着重要作用。细胞周期蛋白依赖性激酶 9(CDK9)刺激大量生存蛋白的产生,导致癌细胞凋亡受损。然而,尚不清楚 CDK9 是否参与 miR-206 介导的肝癌(HCC)细胞生长抑制。在这项研究中,我们发现 miR-206 的表达水平在 HCC 细胞系中明显低于正常肝细胞系(L02)。同时,CDK9 在 HCC 细胞系中上调。此外,miR-206 通过直接结合其 mRNA 3'UTR 下调 HCC 细胞中的 CDK9,导致 RNA PolII Ser2 磷酸化和 Mcl-1 水平降低。此外,miR-206 抑制细胞增殖,并诱导细胞周期停滞和细胞凋亡。同样,沉默或抑制 CDK9 也抑制细胞增殖,并诱导细胞周期停滞和细胞凋亡。总之,这些结果表明,miR-206 通过靶向 CDK9 抑制 HCC 细胞的生长,提示 miR-206-CDK9 通路可能成为治疗 HCC 的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/cb62d3992883/CAM4-6-2398-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/7632588c6842/CAM4-6-2398-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/9fba13db717b/CAM4-6-2398-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/d0f4197135bf/CAM4-6-2398-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/f266b459d38e/CAM4-6-2398-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/6e5dfa270806/CAM4-6-2398-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/beec1000a609/CAM4-6-2398-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/cb62d3992883/CAM4-6-2398-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/7632588c6842/CAM4-6-2398-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/9fba13db717b/CAM4-6-2398-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/d0f4197135bf/CAM4-6-2398-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/f266b459d38e/CAM4-6-2398-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/6e5dfa270806/CAM4-6-2398-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/beec1000a609/CAM4-6-2398-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/5633544/cb62d3992883/CAM4-6-2398-g007.jpg

相似文献

1
miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9.miR-206 通过靶向 CDK9 抑制肝癌细胞的生长。
Cancer Med. 2017 Oct;6(10):2398-2409. doi: 10.1002/cam4.1188. Epub 2017 Sep 21.
2
miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.微小RNA-4417靶向含三联基序蛋白35(TRIM35)并调节丙酮酸激酶M2型(PKM2)磷酸化,以促进肝癌细胞增殖并抑制其凋亡。
Med Sci Monit. 2017 Apr 10;23:1741-1750. doi: 10.12659/msm.900296.
3
Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.在乙型肝炎病毒相关的肝癌细胞中上调的miR-331-3p,通过靶向ING5促进肝癌细胞的增殖。
Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.
4
MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.微小RNA-103通过靶向A激酶锚定蛋白12调控肝细胞癌的生长。
Int J Biochem Cell Biol. 2016 Feb;71:1-11. doi: 10.1016/j.biocel.2015.11.017. Epub 2015 Dec 2.
5
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.EZH2 通过调节 miR-22/galectin-9 轴促进肝癌进展。
J Exp Clin Cancer Res. 2018 Jan 9;37(1):3. doi: 10.1186/s13046-017-0670-6.
6
MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.微小RNA-548a-5p通过靶向Tg737促进肝癌细胞增殖并抑制其凋亡。
World J Gastroenterol. 2016 Jun 21;22(23):5364-73. doi: 10.3748/wjg.v22.i23.5364.
7
MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.微小 RNA-493 通过靶向 ZFX 抑制人肝癌细胞的增殖和侵袭。
Cancer Biomark. 2018;22(3):427-434. doi: 10.3233/CBM-171036.
8
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.一种新型长链非编码 RNA MCM3AP-AS1 通过靶向 miR-194-5p/FOXA1 轴促进肝癌的生长。
Mol Cancer. 2019 Feb 19;18(1):28. doi: 10.1186/s12943-019-0957-7.
9
miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.miR-214/199a/199a*簇水平通过干扰细胞周期调节因子预测肝细胞癌患者的不良生存。
Oncotarget. 2016 Jan 5;7(1):929-45. doi: 10.18632/oncotarget.6137.
10
miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.微小RNA-383通过靶向增殖诱导配体抑制肝癌细胞增殖。
Tumour Biol. 2016 Feb;37(2):2497-507. doi: 10.1007/s13277-015-4071-1. Epub 2015 Sep 18.

引用本文的文献

1
Emerging roles and mechanisms of miR-206 in human disorders: a comprehensive review.miR-206在人类疾病中的新兴作用和机制:综述
Cancer Cell Int. 2022 Dec 17;22(1):412. doi: 10.1186/s12935-022-02833-2.
2
Retracted Article: MiR-206 reduced the malignancy of hepatocellular carcinoma cells by inhibiting MET and CTNNB1 gene expressions.撤回文章:MiR-206通过抑制MET和CTNNB1基因表达降低肝癌细胞的恶性程度。
RSC Adv. 2019 Jan 14;9(3):1717-1725. doi: 10.1039/c8ra09229j. eCollection 2019 Jan 9.
3
FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression NF-κB Signaling.

本文引用的文献

1
The Circulating MicroRNA-206 Level Predicts the Severity of Pulmonary Hypertension in Patients with Left Heart Diseases.循环微小RNA-206水平可预测左心疾病患者肺动脉高压的严重程度。
Cell Physiol Biochem. 2017;41(6):2150-2160. doi: 10.1159/000475569. Epub 2017 Apr 20.
2
Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer.多酚靶向 microRNA:癌症治疗的新策略。
Semin Cancer Biol. 2017 Oct;46:146-157. doi: 10.1016/j.semcancer.2017.02.001. Epub 2017 Feb 7.
3
MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.
受miR-206调控的FER促进肝细胞癌进展及核因子κB信号传导。
Front Oncol. 2021 Jul 5;11:683878. doi: 10.3389/fonc.2021.683878. eCollection 2021.
4
Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma.基于纳米孔 RNA 测序的精确转录组组装揭示了肝癌中的新型功能转录本。
Cancer Sci. 2021 Sep;112(9):3555-3568. doi: 10.1111/cas.15058. Epub 2021 Jul 29.
5
βKlotho, a direct target of miR-206, contributes to the growth of hepatoblastoma through augmenting PI3K/Akt/mTOR signaling.βKlotho是miR-206的直接靶点,通过增强PI3K/Akt/mTOR信号传导促进肝母细胞瘤的生长。
Am J Cancer Res. 2021 May 15;11(5):1982-2004. eCollection 2021.
6
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.细胞周期蛋白依赖性激酶9:对其生物学特性及其作为抗癌药物潜在靶点作用的全面综述
Front Oncol. 2021 May 10;11:678559. doi: 10.3389/fonc.2021.678559. eCollection 2021.
7
MicroRNA-665 facilitates cell proliferation and represses apoptosis through modulating Wnt5a/β-Catenin and Caspase-3 signaling pathways by targeting TRIM8 in LUSC.微小RNA-665通过靶向TRIM8调控Wnt5a/β-连环蛋白和半胱天冬酶-3信号通路,促进肺鳞状细胞癌的细胞增殖并抑制细胞凋亡。
Cancer Cell Int. 2021 Apr 15;21(1):215. doi: 10.1186/s12935-021-01913-z.
8
Prognostic Value and Clinicopathological Features of MicroRNA-206 in Various Cancers: A Meta-Analysis.miRNA-206 在多种癌症中的预后价值及临床病理特征:一项荟萃分析。
Biomed Res Int. 2020 Oct 20;2020:2159704. doi: 10.1155/2020/2159704. eCollection 2020.
9
Ultrasound-Targeted Microbubble Destruction-Mediated miR-206 Overexpression Promotes Apoptosis and Inhibits Metastasis of Hepatocellular Carcinoma Cells Via Targeting PPIB.超声靶向微泡破坏介导 miR-206 过表达通过靶向 PPIB 促进肝癌细胞凋亡和抑制转移。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820959355. doi: 10.1177/1533033820959355.
10
Functional roles of non-coding RNAs regulated by thyroid hormones in liver cancer.甲状腺激素调控的非编码 RNA 在肝癌中的功能作用。
Biomed J. 2021 Jun;44(3):272-284. doi: 10.1016/j.bj.2020.08.009. Epub 2020 Aug 27.
微小RNA-206通过靶向YRDC在膀胱癌中发挥肿瘤抑制作用。
Am J Transl Res. 2016 Nov 15;8(11):4705-4715. eCollection 2016.
4
Inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin in hypopharyngeal carcinoma cells.抑制细胞周期蛋白依赖性激酶9(CDK9)可诱导下咽癌细胞凋亡并增强顺铂的作用。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):536-541. doi: 10.1016/j.bbrc.2016.11.049. Epub 2016 Nov 12.
5
Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.血清miR-206水平升高可预测遗忘型轻度认知障碍向阿尔茨海默病的转化:一项5年随访研究
J Alzheimers Dis. 2017;55(2):509-520. doi: 10.3233/JAD-160468.
6
Targeting CDK9: a promising therapeutic opportunity in prostate cancer.靶向细胞周期蛋白依赖性激酶9:前列腺癌中一个有前景的治疗机会。
Endocr Relat Cancer. 2016 Dec;23(12):T211-T226. doi: 10.1530/ERC-16-0299. Epub 2016 Aug 31.
7
MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2.微小RNA-206通过BCL-2抑制胶质母细胞瘤的进展。
J Mol Neurosci. 2016 Dec;60(4):531-538. doi: 10.1007/s12031-016-0824-6. Epub 2016 Aug 25.
8
PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.PAX7是微小RNA-206诱导融合阴性横纹肌肉瘤分化所需的靶点。
Cell Death Dis. 2016 Jun 9;7(6):e2256. doi: 10.1038/cddis.2016.159.
9
LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer.长链非编码RNA-RMRP通过充当miR-206的海绵促进癌变,并被用作胃癌的一种新型生物标志物。
Oncotarget. 2016 Jun 21;7(25):37812-37824. doi: 10.18632/oncotarget.9336.
10
Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.用于癌症治疗的细胞周期蛋白依赖性激酶9抑制剂
J Med Chem. 2016 Oct 13;59(19):8667-8684. doi: 10.1021/acs.jmedchem.6b00150. Epub 2016 Jun 3.